Jazz Pharmaceuticals plc (JAZZ)
NASDAQ · Healthcare
Jazz Pharmaceuticals plc Operating Income 2009–2025
Jazz Pharmaceuticals plc annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Jazz Pharmaceuticals plc operating income for the quarter ending March 31, 2026 was 336.6 M, a 702.15% decrease year-over-year.
- Jazz Pharmaceuticals plc operating income for the twelve months ending March 31, 2026 was -348.2 M, a 149.86% decrease year-over-year.
- Jazz Pharmaceuticals plc annual operating income for 2025 was -430.2 M, a 160.04% decrease from 2024.
- Jazz Pharmaceuticals plc annual operating income for 2024 was 716.6 M, a 23.86% increase from 2023.
- Jazz Pharmaceuticals plc annual operating income for 2023 was 578.6 M, a 982.95% decrease from 2022.
- Jazz Pharmaceuticals plc annual operating income for 2022 was -65.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Jazz Pharmaceuticals plc Operating Income — FAQ
Jazz Pharmaceuticals plc (JAZZ) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Jazz Pharmaceuticals plc's operating income?
Jazz Pharmaceuticals plc (JAZZ) reported operating income of -$430M for fiscal 2025.
Where can I see JAZZ's operating income history?
The chart and table above show Jazz Pharmaceuticals plc's operating income by year and by quarter, including the growth rate.